Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison-Reference-Cited by-同舟云学术

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Published:2017-06 Issue:2 Volume:16 Page:e15-e22
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Masuishi Toshiki,Taniguchi Hiroya^ORCID,Hamauchi Satoshi,Komori Azusa,Kito Yosuke,Narita Yukiya,Tsushima Takahiro,Ishihara Makoto,Todaka Akiko,Tanaka Tsutomu,Yokota Tomoya,Kadowaki Shigenori,Machida Nozomu,Ura Takashi,Fukutomi Akira,Ando Masashi,Onozawa Yusuke,Tajika Masahiro,Yasui Hirofumi,Muro Kei,Mori Keita,Yamazaki Kentaro

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference19 articles.

1. Globocan. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx. Accessed: February 28, 2015.

2. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004

3. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N Engl J Med,2004

4. Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study;Saltz;J Clin Oncol,2008

5. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Regorafenib and Trifluridine/Tipiracil According to Extended RAS Evaluation in Advanced Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Analysis;Targeted Oncology;2024-04-13

2. Fruquintinib as new treatment option in metastatic colorectal cancer patients: is there an optimal sequence?;Expert Opinion on Pharmacotherapy;2024-03-03

3. Prognostic factors in refractory metastatic colorectal cancer patients treated with Trifluridine/Tipiracil;Journal of Cancer Research and Clinical Oncology;2023-06-15

4. Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study;Current Oncology;2023-06-04

5. Trifluridine/tipiracil (FTD/TPI) and regorafenib in older patients with metastatic colorectal cancer;Journal of Geriatric Oncology;2023-05